|
|
||||||||
Wellcome Trust Cellular Physiology Research Unit, Department of Physiology, University College Cork, Ireland
| Abstract |
|---|
| Introduction |
|---|
|
|
|---|
The classic pathway for steroid action involves the binding of hormone to a specific intracellular receptor [e.g., aldosterone binding to the cytosolic mineralocorticoid type I receptor]. The receptor-steroid complex interacts with hormone-responsive elements located within target genes, initiating transcription and de novo protein synthesis. The steroid-induced proteins influence various cell functions (Fig. 1
). Genomic effects of steroid hormones are characterized by a latency of onset of 28 h and a sensitivity to inhibitors of transcription and translation, such as actinomycin D or cycloheximide. The genomic pathway can also be inhibited by specific antagonists of the various intracellular receptors.
|
| Nongenomic targets of aldosterone |
|---|
|
|
|---|
In extrarenal, nonepithelial cells, aldosterone has been reported to produce rapid in vitro effects (onset within 12 min) on intracellular electrolyte concentrations, cell volume, Na+/H+ exchange, and inositol 1,4,5-trisphosphate production in human mononuclear leukocytes (17). Rapid effects of aldosterone on free intracellular Ca2+ concentration ([Ca2+]i), phospholipase C, diacylglycerol, and protein kinase C (PKC) have been demonstrated in endothelial and vascular smooth muscle cells (17). In vascular tissue, the rapid responses to aldosterone may be important in the acute control of blood pressure (17).
Mammalian distal colon is a major target for aldosterone action (6), and the level of mineralocorticoid receptor gene expression is higher in the distal colon than in other target tissues such as the kidney or hippocampus (7). Recent studies from our laboratory (4, 5, 11) have demonstrated rapid (<1 min) nongenomic activation of Na+/H+ exchange, K+ recycling, and PKC activity, specifically by mineralocorticoids (glucocorticoids were without effect) in human and rat distal colon. The primary ion transport target of the nongenomic signal transduction cascades elicited by aldosterone in epithelia is the Na+/H+ exchanger at the basolateral cell membrane. In isolated colonic crypts, aldosterone produces an intracellular alkalinization within 1 min of hormone addition (17). Inhibition of PKC activity prevents the cellular alkalinization induced by aldosterone. Because serine kinases are important regulators of the Na+/H+ exchanger, it is likely that rapid activation of PKC by aldosterone mediates the nongenomic stimulation of the exchanger. The effect of aldosterone on Na+/H+ exchange appears to be ubiquitous in mineralocorticoid-receptive epithelia such as human sweat gland, renal collecting duct, and amphibian skin (8, 9, 15).
In pluripotential epithelia (tissues capable of simultaneous secretion and absorption), the rapid activation of Na+/H+ exchange and the resulting intracellular alkalinization have important consequences for transepithelial ion transport. An increase in intracellular pH (pHi) produces opposite effects on two classes of basolateral K+ channels: an ATP-sensitive K+ (KATP) channel and a Ca2+-sensitive K+ (KCa) channel. The KATP channel is stimulated by increases in pHi, and this channel is involved in K+ recycling to maintain the electrical driving force for amiloride-sensitive Na+ absorption. In contrast, the KCa channels are inhibited by cellular alkalinization, and these channels generate the charge balance for Cl secretion (11). At physiological concentrations (0.11 nM), aldosterone activates the KATP conductance and inhibits the KCa conductance within 5 min in human distal colon (11). Stimulation of PKC and Na+/H+ exchanger activity are required for these rapid effects. Thus it would appear that the nongenomic response to aldosterone in pluripotential epithelia is to enhance the capacity for absorption while downregulating the potential for secretion (Fig. 2
).
|
| Cell signaling responses to aldosterone |
|---|
|
|
|---|
in a cell-free assay system containing only purified commercially available enzyme, appropriate substrate peptide, cofactors, and lipid vesicles (3). Aldosterone did not stimulate the activity of the other PKC isoforms known to be present in distal colonic epithelium: PKC-
, -
, and -
(2). In addition, aldosterone stimulates PKC-dependent Ca2+ entry through an L-type channel in rat and human distal colonic crypts (4, 5).
These results demonstrate a direct and specific interaction of aldosterone with the Ca2+-sensitive PKC isoform PKC-
. Thus PKC-
is a candidate nongenomic receptor for aldosterone (Fig. 3
). There is also evidence that more than one receptor is involved in the nongenomic aldosterone response. Arachidonic acid release via the phospholipase A2 pathway is also an important step in transducing rapid responses to aldosterone. Pretreatment with the G protein inhibitor pertussis toxin and the phospholipase A2 antagonist quinacrine significantly inhibited aldosterone-induced stimulation of the Na+/H+ exchanger and KATP current in colonic cells. Inhibition of prostaglandin synthesis via the cyclooxygenase pathway abolished the stimulatory response to the steroid hormone. Conversely, inhibition of the lipoxygenase pathway did not prevent the increase in KATP channel activity or activation of the Na+/H+ exchanger induced by aldosterone (18). The results of these studies indicate that, in addition to PKC, there may be a role for membrane-associated signaling in the transduction of rapid steroid hormone responses on ion transport and pHi regulation in pluripotential epithelia.
|
| Rapid nongenomic targets of estradiol |
|---|
|
|
|---|
A possible physiological function of estradiol may be to alter transepithelial ion transport. Plasma estrogen concentrations increase dramatically during gestation and in other high-estrogen states such as certain phases of the menstrual cycle and following use of the combined oral contraceptive pill. High estrogen states are associated with salt and water retention, resulting in edema and hypertension (cf. Ref. 3). This observation supports a role for estradiol in whole body salt and water homeostasis.
The transcellular movement of Cl drives the efflux of salt and water in many secretory epithelia. Basolateral KCa channels play an important role in this process, because blockade of these channels reduces both basal Cl secretion and Cl secretion prestimulated by secretagogues (10). Estradiol has been shown to rapidly inhibit basolateral KCa channel activity, which would be expected to result in an acute inhibition of Cl secretion (Fig. 2
). Recently, we have shown that physiological concentrations of estradiol (0.110 nM) reduce both basal and secretagogue-induced Cl secretion (1). The antisecretory effect of estradiol is sensitive to PKC inhibition or intracellular Ca2+ chelation and is gender specific, occurring only in tissues of female origin. These observations link nongenomic second messengers with a rapid, gender-specific effect in the whole tissue. The nongenomic effect of estradiol to decrease Cl secretion occurs only in epithelia of female origin and may underlie the increased salt and water retention observed clinically in high-estrogen states.
| Cell signaling responses to estradiol |
|---|
|
|
|---|
Because the only known physiological regulator of PKA is cAMP, the stimulatory effect of estradiol on PKA activity must be indirect since the nongenomic response is sensitive to adenylyl cyclase inhibition and is mimicked by forskolin. Also, the hormone does not cause a direct stimulation of PKA activity in either type I or type II commercially available PKA holoenzymes (3). The most obvious conclusion therefore is that estradiol stimulates adenylyl cyclase activity indirectly to produce the nongenomic effect on PKA.
It has previously been demonstrated (19) that certain isoforms of adenylyl cyclase are activated by PKC. Estradiol produces a rapid stimulation of PKC activity in rat distal colonic epithelium (4), and it is possible that the estradiol-stimulated PKA activity is mediated via this pathway. This conclusion is reinforced by the observation that specific PKC antagonists inhibit the estradiol-induced stimulation of PKA activity. In contrast, however, PKC inhibition has no inhibitory effect on cAMP-stimulated PKA activity. Estradiol stimulation of PKA involves an initial activation of PKC before upregulation of adenylyl cyclase activity (3). This effect is PKC isoform specific (Fig. 3
).
Estradiol directly and specifically stimulates PKC-
activity in a cell-free assay system. Other steroid hormones such as 17
-estradiol, progesterone, testosterone, aldosterone, hydrocortisone, and dexamethasone are without effect on PKC-
activity. Estradiol also activates PKC-
. However, the involvement of this Ca2+- and phospholipid-dependent PKC isoform in the estradiol-induced stimulation of PKA activity can be ruled out. Both aldosterone and the stereoisomer 17
-estradiol, which activate PKC-
, have no stimulatory effect on PKA (3). We propose, therefore, that the cytosolic protein responsible for the rapid nongenomic PKA response to estradiol is the Ca2+-independent, phospholipid-dependent PKC-
isoform. The PKC-
isoform may be a nongenomic receptor for estradiol (Fig. 3
).
| Common and divergent signaling pathways for rapid effects of aldosterone and estradiol |
|---|
|
|
|---|
Initially, there appeared to be a common stimulatory signaling pathway for rapid nongenomic responses to aldosterone and estradiol, i.e., PKC. Our recent results (3) now suggest that these steroid hormones stimulate different PKC isozymes, with aldosterone stimulating PKC-
selectively and estradiol stimulating both PKC-
and PKC-
. These results indicate both common and divergent signaling systems for salt-retaining steroid hormones. These properties could offer an explanation for common transporter targeting and yet confer gender specificity.
| Conclusion |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
-25 dihydroxyvitamin D3. J Biol Chem 270: 66396643, 1995.This article has been cited by other articles:
![]() |
A. Smith, C. Contreras, K. H. Ko, J. Chow, X. Dong, B. Tuo, H.-h. Zhang, D.-b. Chen, and H. Dong Gender-Specific Protection of Estrogen against Gastric Acid-Induced Duodenal Injury: Stimulation of Duodenal Mucosal Bicarbonate Secretion Endocrinology, September 1, 2008; 149(9): 4554 - 4566. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Groban, L. M. Yamaleyeva, B. M. Westwood, T. T. Houle, M. Lin, D. W. Kitzman, and M. C. Chappell Progressive Diastolic Dysfunction in the Female mRen(2).Lewis Rat: Influence of Salt and Ovarian Hormones J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2008; 63(1): 3 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. O'Mahony, R. Alzamora, V. Betts, F. LaPaix, D. Carter, M. Irnaten, and B. J. Harvey Female Gender-specific Inhibition of KCNQ1 Channels and Chloride Secretion by 17beta-Estradiol in Rat Distal Colonic Crypts J. Biol. Chem., August 24, 2007; 282(34): 24563 - 24573. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Good Nongenomic Actions of Aldosterone on the Renal Tubule Hypertension, April 1, 2007; 49(4): 728 - 739. [Full Text] [PDF] |
||||
![]() |
B. A. Watts III, T. George, and D. W. Good Aldosterone inhibits apical NHE3 and HCO3- absorption via a nongenomic ERK-dependent pathway in medullary thick ascending limb Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1005 - F1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Good, T. George, and B. A. Watts III Nongenomic regulation by aldosterone of the epithelial NHE3 Na+/H+ exchanger Am J Physiol Cell Physiol, March 1, 2006; 290(3): C757 - C763. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Hillebrand, M. Hausberg, C. Stock, V. Shahin, D. Nikova, C. Riethmuller, K. Kliche, T. Ludwig, H. Schillers, S.W. Schneider, et al. 17{beta}-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange Cardiovasc Res, March 1, 2006; 69(4): 916 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Chernova, D. H. Vandorpe, J. S. Clark, J. I. Williams, M. A. Zasloff, L. Jiang, and S. L. Alper Apparent receptor-mediated activation of Ca2+-dependent conductive Cl- transport by shark-derived polyaminosterols Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1644 - R1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Verriere, D. Hynes, S. Faherty, J. Devaney, J. Bousquet, B. J. Harvey, and V. Urbach Rapid Effects of Dexamethasone on Intracellular pH and Na+/H+ Exchanger Activity in Human Bronchial Epithelial Cells J. Biol. Chem., October 28, 2005; 280(43): 35807 - 35814. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M C Connell and E. Davies The new biology of aldosterone J. Endocrinol., July 1, 2005; 186(1): 1 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Vasan, J. C. Evans, E. J. Benjamin, D. Levy, M. G. Larson, J. Sundstrom, J. M. Murabito, F. Sam, W. S. Colucci, and P. W. F. Wilson Relations of Serum Aldosterone to Cardiac Structure: Gender-Related Differences in the Framingham Heart Study Hypertension, May 1, 2004; 43(5): 957 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Good, T. George, and B. A. Watts III Aldosterone potentiates 1,25-dihydroxyvitamin D3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1122 - C1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Good, T. George, and B. A. Watts III Aldosterone inhibits HCO-3 absorption via a nongenomic pathway in medullary thick ascending limb Am J Physiol Renal Physiol, October 1, 2002; 283(4): F699 - F706. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hatzoglou, K. I. Gourgoulianis, A. Hatzoglou, E. Castanas, and P. A. Molyvdas Rapid effects of 17beta -estradiol and progesterone on sheep visceral and parietal pleurae via a nitric oxide pathway J Appl Physiol, August 1, 2002; 93(2): 752 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Stockand New ideas about aldosterone signaling in epithelia Am J Physiol Renal Physiol, April 1, 2002; 282(4): F559 - F576. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Booth, J. P. Johnson, and J. D. Stockand ALDOSTERONE Advan Physiol Educ, March 1, 2002; 26(1): 8 - 20. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |